)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
ALK-Abelló (ALK) investor relations material
ALK-Abelló Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Achieved 18% organic revenue growth and 41% EBIT increase in Q3 2025, driven by strong performance in tablets, adrenaline autoinjectors, and SCIT/SLIT-drops, supported by strategic initiatives and robust product launches.
Expansion in China through a new GenSci partnership and successful launches of key products for children and anaphylaxis, with early uptake of ITULAZAX® and ACARIZAX® for children exceeding expectations.
Upgraded full-year outlook due to robust business momentum, especially in Europe, and strong paediatric roll-out of house dust mite and tree pollen tablets.
Launched EURneffy® nasal adrenaline spray in the UK and advanced peanut SLIT-tablet development with FDA Fast Track status.
Financial highlights
Q3 2025 revenue increased by 18% year-over-year to DKK 1,530 million, with EBIT up 41% to DKK 423 million and EBIT margin improving to 28% from 22-23% last year.
Gross margin improved to 68% in Q3 2025 (67% for 9M 2025), up from 64% in the prior year.
Free cash flow for the first nine months reached DKK 836 million, up from DKK 425 million year-over-year; Q3 free cash flow was DKK 290 million.
Net profit for Q3 was DKK 314 million, up from DKK 212 million in Q3 2024.
For the first nine months, revenue grew 14% to DKK 4,579 million; EBIT up 44% to DKK 1,267 million.
Outlook and guidance
2025 revenue growth guidance raised to 13-15% in local currencies (previously 12-14%), with EBIT margin expected at approximately 26%.
Growth to be volume-driven across all regions, with double-digit tablet sales and single-digit SCIT/SLIT-drops sales.
Free cash flow forecast raised to exceed DKK 1 billion for the year.
R&D costs to remain around 10% of revenue, with increased S&M and administrative costs.
China HDM tablet launch: Key milestones?
EURneffy®: How to overcome adoption barriers?
Q4 EBIT margin: What drives the expected dip?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ALK-Abelló earnings date
Q4 202519 Feb, 2026
Next ALK-Abelló earnings date
Q4 202519 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company produces test kits for allergy and asthma assessment; allergy alert systems; blood pressure monitors; clinical chemistry analyzers; immunoassays and biochemistry instruments, Bruker X-ray fluorescence spectrometers, and various other products. It also provides allergy diagnostic solutions, including skin testing systems; test kits to identify urushiols that cause natural rubber allergies; laboratory equipment to measure patient serum samples suspected of having restricted proteins; a compact EDM device that helps dermatologists treat contact dermatitis via electromagnetic healing vibrations; a patch test panel to help prevent hospital patients from developing hypersensitivity and subsequent allergies during their stay; a test kit for the identification of contact urticaria triggered by nickel based alloys used in jewellery making and dental implants.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage